Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
http://www.pharmaceutical-technology.com/data-insights/ac-0676-accutar-biotechnology-follicular-lymphoma-likelihood-of-approval/
0
0
AC-0676 by Accutar Biotechnology for Follicular Lymphoma: Likelihood of Approval - Pharmaceutical Technology
7/8/23 at 1:45am
Organization
Pharmaceutical Technology
Author
kgi-admin
Details
30 words
Summarize
Cancer
Air-Conditioning
Pharmaceuticals & Biotech
Accutar Biotechnology for Follicular Lymphoma: Likelihood of Approval - Pharmaceutical Technology AC-0676
Follicular Lymphoma
Accutar Biotechnology
AC-0676 is under clinical development by Accutar Biotechnology and currently in Phase I for Follicular Lymphoma.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...